Manulife Financial Corporation’s Money Magic

Is Manulife Financial Corporation (TSX:MFC)(NYSE:MFC) a safe alternative to the banks?

| More on:
The Motley Fool

In this age of low interest rates, investors who favour financial companies have limited options, either you favour the banks or insurance companies. Many have sided with the banks because the low interest rates tend to limit the bottom line of insurance companies.

Now Manulife Financial Corporation (TSX: MFC)(NYSE: MFC) has released its third-quarter report so let’s investigate to see if it’s time for insurance companies to shine in your portfolio.

Q3 results

Before we begin, two years ago Manulife restructured its earnings reporting structure by replacing revenues with “core earnings”. This in essence limits any direct impact from interest rates, unsteady equity markets and several one-time items from skewing top line results.

Core earnings in Q3 2014 came in at $755 million up from $704 million during the same period last year. This is good news for the company and investors as this keeps the company on track to meet its 2016 target of $4 billion in core earnings annually.

Manulife’s management has reiterated recently that it “doesn’t want to be so beholden to a target that we will make sacrifices with respect to the long-term health of the business in order to meet that target.”

Net income (attributable to shareholder) saw a modest gain totalling $1.1 billion ($0.57 per diluted share) up from $1.03 billion ($0.49 per diluted share) during the same period last year.

While core earnings and net income are up, there are some areas of concern as Manulife’s return on equity fell in the quarter to 14.8% from the 16.8% generated last year. Despite these lower earnings, Manulife has managed to post 24 consecutive quarters of record funds under management, which now totals over $663 billion.

Asian growth

It was a very good quarter for Manulife and its operations in Asia, with highlights such as an 83% increase in insurance sales in Japan that totalled US$165 million. The company also enjoyed a 37% increase in insurance sales in Hong Kong, a 14% increase in insurance sales in Indonesia and 16% growth in its “Asia other” territories.

Wealth sales in Asia rose an astounding 74% compared to Q3 2013 coming in at US$2.2 billion, but its year-to-date results have fallen by 14% to $5.6 billion.

Overall wealth sales in the quarter fell by 15% as these double-digit increases in its Asian operation were not enough to make up for Manulife’s North American operations.

Are the home fires dwindling?

Here in Canada, Manulife’s insurance sales fell to $143 million a drop of 23% over last year’s quarter and year-to-date sales are down by 58%. Group benefits appear to be a major source of the lost revenues — when group benefits are removed from the results, insurance sales are up by 5% for the quarter.

Down south, U.S. insurance sales dropped by 19% compared to Q3 2013 and year-to-date insurance sales are down by 19%.

Standard Life Canada purchase a go

One bit of good news that should fatten up the books for the Q4/year-end release is that the Federal Competition Bureau has approved Manulife’s $4 billion offer to purchase the Canadian operations of Standard Life PLC. This will give Manulife a sizeable footprint in Quebec, a province where Manulife has seen lackluster development.

Overall this was a very mixed bag of results for Manulife. Its North American growth is slowing down and the company is riding on its Asian expansions. But for how long? Competition is just as fierce across the Pacific and it still has to contend with several of its Canadian competitors there as well, including the banks.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Cameron Conway has no position in any stocks mentioned.

More on Investing

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Woman has an idea
Investing

3 No-Brainer Stocks to Buy With $200 Right Now

These three stocks are no-brainer buys, given their solid underlying businesses and healthy growth prospects.

Read more »

Investing

2 Stocks I’m Loading Up on in 2024

Alimentation Couche-Tard (TSX:ATD) and another stock that are getting too cheap after their latest corrections.

Read more »

grow money, wealth build
Dividend Stocks

1 Top Dividend Stock That Can Handle Any Kind of Market (Even Corrections)

While most dividend aristocrats can maintain their payouts during weak markets, very few can maintain a healthy valuation or bounce…

Read more »

Red siren flashing
Dividend Stocks

Income Alert: These Stocks Just Raised Their Dividends

Three established dividend-payers from different sectors are compelling investment opportunities for income-focused investors.

Read more »

online shopping
Tech Stocks

1 Hidden Catalyst That Could Ignite Shopify Stock

Here's why Shopify (TSX:SHOP) ought to remain a top growth stock investors continue to focus on for the long haul.

Read more »

Oil pumps against sunset
Energy Stocks

Is it Too Late to Buy Enbridge Stock?

Besides its juicy and sustainable dividends, Enbridge’s improving long-term growth prospects make it a reliable stock to hold for the…

Read more »

Man considering whether to sell or buy
Tech Stocks

WELL Stock: Buy, Sell, or Hold?

WELL stock has a lot of upside as the company is likely to continue to grow, posting positive earnings in…

Read more »